DVT/PE are often underdiagnosed and serious, but preventable medical conditions. It is important to know about DVT because it can happen to anybody at any age and can cause serious illness, disability, and in some cases, death. The good news is that DVT is preventable and treatable if discovered early.
DVT/PE: What's New
- 10/2—Test Your Knowledge! How much do you know about Healthcare-associated Blood Clots?
- 10/2—Healthcare Providers: Test Your Knowledge! How much do you know about Healthcare-associated Blood Clots?
- 9/28—New materials on healthcare-associated VTE
- 8/17—Infographic: Know the Risks, Signs, and Symptoms of Blood Clots
- 8/17—Infographic: Impact of Blood Clots on the U.S.
Read stories about people living with DVT/PE.
Bleeding and Clotting Disorders
The purpose of this series is to provide evidence-based information on new research, interventions, emerging issues of interest in blood disorders, as well as innovative approaches in collaborations and partnerships. We invite you to join us in this series.
Watch this short video above to learn more about blood clots and your potential risk factors.
Webinar Coming Soon
Prevention and Treatment of Venous Thromboembolism During Pregnancy
Andra H. James, MD, MPH, Consulting Professor of Obstetrics and Gynecology at Duke University
When: October 13, 2015, 2:00 – 3:00 pm EST
October 13 marks World Thrombosis Day—a day to focus attention on the often overlooked and misunderstood disease of thrombosis. The International Society on Thrombosis and Haemostasis (ISTH) is proud to collaborate with the Centers for Disease Control and Prevention (CDC) in supporting World Thrombosis Day and the efforts to place a global spotlight on thrombosis as an urgent and growing public health problem. In honor of World Thrombosis Day, ISTH and CDC are co-hosting a special webinar on venous thromboembolism (VTE) and pregnancy. Pregnant women are especially at increased risk for thrombosis, particularly venous thromboembolism (VTE). Women who have a history of thrombosis or inherited or acquired risk factors for VTE (also known as thrombophilias) may be much more likely to develop VTE when pregnant. Additionally, pregnant women who are hospitalized or have surgery are at increased risk for developing healthcare-associated VTE (HA-VTE). In this webinar, Dr. James will discuss the key issues concerning the occurrence of VTE during pregnancy and the postpartum period.
- Describe the epidemiology of pregnancy-related thrombosis.
- Describe the underlying biologic changes and causes of pregnancy-related VTE.
- List the risk factors for VTE at the time of childbirth and in the postpartum period.
- List the strategies for managing and preventing VTE at the time of childbirth and during the months after delivery.
- Describe an appropriate risk assessment of VTE for pregnant women.
- Describe how to talk with patients about their risks for HA-VTE.
This webinar is free and open to public health professionals, clinicians, and researchers who desire more information about VTE and pregnancy. Please register here.
- Page last reviewed: October 2, 2015
- Page last updated: October 2, 2015
- Content source: